Clinically significant symptoms prevalence in breast and colon cancers and leukemia patients: a comparison analysis of patient-reported outcomes

被引:0
作者
Isamme AlFayyad
Mohamad Al-Tannir
Amjad AlShammari
机构
[1] King Fahad Medical City,Research Center
[2] King Fahad Medical City,Pharmacy Administration
来源
Supportive Care in Cancer | 2022年 / 30卷
关键词
Clinically significant symptoms; Cancer; Breast; Colon; Leukemia; Distress;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:439 / 446
页数:7
相关论文
共 45 条
  • [41] Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients - a simulation study
    Sebille, Veronique
    Hardouin, Jean-Benoit
    Le Neel, Tanguy
    Kubis, Gildas
    Boyer, Francois
    Guillemin, Francis
    Falissard, Bruno
    BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
  • [42] Patient-Reported Outcomes Over 5 Years After Whole-or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial
    Bhattacharya, Indrani S.
    Haviland, Joanne S.
    Kirby, Anna M.
    Kirwan, Cliona C.
    Hopwood, Penelope
    Yarnold, John R.
    Bliss, Judith M.
    Coles, Charlotte E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 305 - +
  • [43] Comparison of statistical methods for the analysis of patient-reported outcomes (PROs), particularly the Short-Form 36 (SF-36), in randomised controlled trials (RCTs) using standardised effect size (SES): an empirical analysis
    Qian, Yirui
    Walters, Stephen J.
    Jacques, Richard M.
    Flight, Laura
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2025, 23 (01)
  • [44] The effectiveness of symptom management interventions based on electronic patient-reported outcomes (ePROs) for symptom burden, quality of life, and overall survival among patients with cancer: A meta-analysis of randomized controlled trials
    Li, Yunhuan
    Li, Juejin
    Hu, Xiaolin
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2023, 147
  • [45] Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
    Gwark, Sungchan
    Ahn, Sei Hyun
    Noh, Woo Chul
    Lee, Eun Sook
    Jung, Yongsik
    Kim, Lee Su
    Han, Wonshik
    Nam, Seok Jin
    Gong, Gyungyub
    Kim, Seon-Ok
    Kim, Hee Jeong
    FRONTIERS IN ONCOLOGY, 2021, 11